Associations of modifiable preconception, pregnancy and postpartum factors with health outcomes for women with type 2 diabetes and their children: A systematic review and meta‐analysis of observational studies
Open Access
- 7 December 2025
- journal article
- review article
- Published by Wiley in Diabetic Medicine
- Vol. 43 (2) , e70183
Abstract
Aim: Type 2 diabetes (T2D) in pregnancy is increasingly common and associated with suboptimal outcomes for these women and their children. We aimed to synthesize observational evidence on associations of modifiable preconception, pregnancy and postpartum risk factors with perinatal outcomes among women with pregestational T2D. Methods: Searches were conducted in six databases (September 2023). Observational studies among women with pregestational T2D were included if they reported associations of modifiable risk factors with maternal and/or child outcomes. Screening, data extraction and quality assessments were conducted by two reviewers. Findings were synthesized through random effects meta‐analysis or narrative synthesis when results were too few or heterogeneous to pool. Results: Searches identified 15,578 results; 58 studies were included. Meta‐analysis showed excessive gestational weight gain (GWG) was associated with large for gestational age (LGA) (OR 2.39, 95%CI 1.74–3.29) but not small for gestational age (SGA). Meta‐analysis demonstrated no associations between preconception care or metformin use with adverse pregnancy, birth and neonatal outcomes. However, narrative synthesis showed preconception care was associated with increased use of folic acid and vitamin D, and reduced GWG. Further narrative synthesis findings showed that higher BMI was associated with multiple suboptimal pregnancy, birth and neonatal outcomes. Excessive GWG was associated with increased insulin requirements and increased likelihood of neonatal hypoglycaemia. The use of metformin/oral hypoglycaemic medications was associated with reduced GWG and fewer caesarean deliveries. There was mixed or no evidence of association for other reported exposures and outcomes. Conclusion: Based on observational evidence, increasing access to preconception care could be beneficial to optimize maternal nutrition and weight‐related outcomes, and addressing obesity and GWG has the potential to improve maternal and neonatal outcomes in pregnancies affected by T2D.Keywords
Funding Information
- European Foundation for the Study of Diabetes
- Diabetes UK
- Medical Research Council
- National Institute for Health and Care Research
This publication has 81 references indexed in Scilit:
- Safety of GLP-1 Receptor Agonists and Other Second-Line Antidiabetics in Early PregnancyJAMA Internal Medicine, 2024
- Metformin Plus Insulin for Preexisting Diabetes or Gestational Diabetes in Early PregnancyJAMA, 2023
- Severe birth injuries in neonates and associated risk factors for injury in mothers with different types of diabetes in FinlandInternational Journal of Gynecology & Obstetrics, 2022
- Cochrane Handbook for Systematic Reviews of Interventions2019
- Maternal and neonatal outcomes following a diabetic pregnancy within the context ofHIVInternational Journal of Gynecology & Obstetrics, 2019
- Association of Gestational Weight Gain With Adverse Maternal and Infant OutcomesJAMA, 2019
- Improved pregnancy outcomes in women with type 1 and type 2 diabetes but substantial clinic-to-clinic variations: a prospective nationwide studyDiabetologia, 2017
- Maternal overweight and obesity and risk of pre-eclampsia in women with type 1 diabetes or type 2 diabetesDiabetologia, 2016
- Progression of diabetic retinopathy during pregnancy in women with type 2 diabetesDiabetologia, 2010
- Publication Bias in Meta‐Analysis2005